Figure 1 | Scientific Reports

Figure 1

From: Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B

Figure 1

(a) The proportion of patients with CHB and participants in the general population with hepatic steatosis stage S0 (< 248 dB/m), S1 (248–268 dB/m), S2 (268–280 dB/m), and S3 (≥ 280 dB/m), which was determined from CAP measurement. (b) Prevalence of hepatic steatosis in subjects with and without hepatitis B virus infection stratified by age.

Back to article page